Suggestions
Scott Howell
Chief Strategy Officer, US Pharmaceuticals, Novartis
Scott Howell is an accomplished healthcare executive with extensive experience in the pharmaceutical and healthcare industry. He served as the Chief Strategy Officer for US Pharmaceuticals at Novartis from December 2020 to May 2022.2 In this role, he led a Commercial Model Transformation for Novartis, as well as US Business Development & Licensing and the Value Based Pricing & Access team.1
Howell's career spans over 30 years across various healthcare segments, including:
- Clinical practice and administration
- Managed care
- Pharmaceuticals and biotech
- Distribution
- Specialty pharmacy
He has held leadership positions at several prominent companies, including:
- Novartis (2017-2022)
- Jazz Pharmaceuticals (2016-2017)
- Cardinal Health (2013-2015)
- Genentech (2006-2013)
- Highmark Blue Cross Blue Shield (2005-2006)
- GSK (1997-2005)
Howell began his career as a general internist and worked in private practice before entering academic medicine at The Ohio State University.12 He holds an M.D. from The Ohio State University and an MBA from Duke University.2
Currently, Howell is involved in biopharma and health tech advisory through his company, Blue Line Advisors, LLC.2 He is also a guest lecturer at the University of California, Berkeley, where he has been teaching since 2008.2